Skip to main content

Table 1 Summary of the number of metabolic features that show statistically significant differences (P < 0.05) in each group comparison for each independent study and the number of features that are statistically significant in both independent studies

From: Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA)

Comparison

Study 1 (P< 0.05)

Study 2 (P< 0.05)

Both studies (P< 0.05)

Non-diabetic/TETA-treated rats versus non-diabetic/untreated rats

234

211

5

Non-diabetic/TETA-treated rats versus STZ-induced diabetic/TETA-treated rats

1,129

3,077

576

Non-diabetic/TETA-treated rats versus STZ-induced diabetic/untreated rats

1,310

2,943

623

Non-diabetic/untreated rats versus STZ-induced diabetic/TETA-treated rats

1,480

3,308

768

Non-diabetic/untreated rats versus STZ-induced diabetic/untreated rats

1,677

2,982

791

STZ-induced diabetic/TETA-treated rats versus STZ-induced diabetic/untreated rats

145

406

12

  1. STZ, streptozotocin; TETA, triethylenetetramine.